Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Doripenem

A broad-spectrum carbapenem antibiotic developed in Japan, first marketed there in 2005 and approved in the United States in 2007 for complicated abdominal and urinary tract infections. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?Compared with earlier carbapenems it is more stable in water-based solution, so it can be given as prolonged infusions; it is also particularly active against Pseudomonas aeruginosa.

DoripenemGo to the active ingredient →
DoripenemActive ingredientDoripenemCat. No. P-D174-001CAS 148016-81-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.